Interleukin Genetics' Q2 Revenues Decline | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic test maker Interleukin Genetics reported after the close of the market Thursday that its second-quarter revenues fell 57 percent year over year due to lower contract research revenue.

The Waltham, Mass.-based firm generated total revenues of $222,993 for the three-month period ended June 30, down from total revenues of $521,619 for the second quarter of 2008. The company's contract service revenues fell sharply to $119,046 from $402,280, while its genetic testing service revenue increased to $95,309 from $90, 993.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.